Course Summary

Many types of skin diseases can occur in people that range in onset and severity. Dermatological treatment may be directed toward the management of an inflammatory process, comorbid medical conditions, or it may be cosmetic. There are evolving dermatology drug products and market factors that health clinicians will need to inform patients about when addressing their skin health concerns and treatment choices. The effect of certain dermatological agents in special populations, such as during pregnancy, can range from inconclusive to a known potential risk.

Course Format

Homestudy

Course Syllabus

1. Introduction
2. Skin Disease Classifications and Treatments
   • Topical Agents
3. Antibacterial Agents and Antibiotics
   • Mupirocin
   • Neomycin and Gentamicin
   • Silver Sulfadiazine
   • Erythromycin
   • Clindamycin
   • Metronidazole
4. Antifungals
   • Polyenes
   • Ciclopirox Olamine
   • Terbinafine
5. Topical Retinoids
   • Tretinoin
   • Adapalene
   • Tazarotene
6. Antiviral and Immunosuppressant Agents
   • Azathioprine
   • Methotrexate
   • Cyclosporine
   • Mycophenolate Mofetil
7. Biologics
   • Adalimumab
   • Infliximab
   • Etanercept
   • Golimumab
   • Ustekinumab
8. Case Study: Tattoo-associated Skin Eruptions
9. Summary

Authors

Harpreet Ghai, MS (Pharm), BPharm, Rph

Harpreet Ghai has been a practicing Pharmacist for 12 years in Comox, British Columbia. He has also completed his Master’s in Science, specializing in Medicinal Chemistry from NIPER (National Institute of Pharmaceutical Education and Research), in India. He has spent 3 years in Pharmaceutical Research at Ranbaxy in Gurugram (India), where he was engaged in Structure-based drug designing and was a part of a premier research-intensive group responsible for discovering novel drugs. Harpreet enjoys the day-to-day challenges at the retail pharmacy. Interactions with customers, listening to their drug-related issues, and providing solutions are profoundly rewarding.

Noah H. Carpenter, MD

Dr. Noah Carpenter is a Thoracic and Peripheral Vascular Surgeon. He completed his Bachelor of Science in chemistry and medical school and training at the University of Manitoba. Dr. Carpenter completed surgical residency and fellowship at the University of Edmonton and Affiliated Hospitals in Edmonton, Alberta, and an additional Adult Cardiovascular and Thoracic Surgery fellowship at the University of Edinburgh, Scotland. He has specialized in microsurgical techniques, vascular endoscopy, laser and laparoscopic surgery in Brandon, Manitoba and Vancouver, British Columbia, Canada and in Colorado, Texas, and California. Dr. Carpenter has an Honorary Doctorate of Law from the University of Calgary, and was appointed a Citizen Ambassador to China, and has served as a member of the Indigenous Physicians Association of Canada, the Canadian College of Health Service Executives, the Science Institute of the Northwest Territories, Canada Science Council, and the International Society of Endovascular Surgeons, among others. He has been an inspiration to youth, motivating them to understand the importance of achieving higher education.